Stay updated on Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Sign up to get notified when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The footer site revision label changed from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-10T20:24:51.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record area displays a 403 Forbidden message and a Home link instead of study details.
    Difference
    0.5%
    Check dated 2026-10-03T19:36:42.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    26 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating access to the study record is blocked. This reflects a site access issue rather than a substantive update to the study content.
    Difference
    17%
    Check dated 2026-09-19T19:05:43.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    A funding note for NIH grant/contract was added to the record, and the page revision was updated from v3.6.5 to v3.6.6.
    Difference
    0.1%
    Check dated 2026-08-29T18:55:20.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision on the page updated from Revision: v3.6.4 to Revision: v3.6.5, indicating a new page revision has been published. This reflects a minor internal update to the page metadata rather than changes to the study's content.
    Difference
    0.0%
    Check dated 2026-08-08T10:00:04.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    The page footer now shows Revision: v3.6.4, replacing v3.6.3, indicating a small update to the ClinicalTrials.gov interface.
    Difference
    0.0%
    Check dated 2026-07-25T06:21:29.000Z thumbnail image

Stay in the know with updates to Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cofetuzumab Pelidotin in PTK7+ NSCLC: Efficacy and Safety Clinical Trial page.